Biomiga

Biomiga developed both mini column and magnetic beads based COVID-19 RNA extraction methods for extracting RNA from nasopharyngeal or oropharyngeal aspirates, washes, swabs, aspirates, and sputum.

  1. Globally, millions of preps have been used successfully for extracting COVID-19 RNA. The isolated RNA can be used for PCR, qRT-PCR and other downstream applications.
  2. Specially formulated Lysis Buffer and Proteinase K provided for effective viral RNA extraction.
  3. Procedure is highly efficient, taking less than 30 minutes. It saves up to 50% of base reagents compared to other competing systems.Products have been selling to over 50 countries including USA, China, Germany, Italy, Poland, Bulgaria, Iraq, Lebanon, Nepal, Brazil, Argentina, Chile, Bolivia, Colombia, Ecuador, Etc.
  4. FDA registered (#3007054022)
  5. FDA Certificate to foreign governments (#5908-2-2021)
  6. CE Certificate (#DE/CA09/0170/B29/IVD/001)

ISO9001:2015 certified (# B063020)

VIRAL RNA EXTRACTION FROM RESPIRATORY SPECIMENS

   (VR6568, mini column based)

                               

VIRAL RNA EXTRACTION FROM RESPIRATORY SPECIMENS

                                  (VR6568, mini column based)

Leave a Reply

Your email address will not be published. Required fields are marked *